These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. The Mitochondria-Targeted Metabolic Tubular Injury in Diabetic Kidney Disease. Jiang H; Shao X; Jia S; Qu L; Weng C; Shen X; Wang Y; Huang H; Wang Y; Wang C; Feng S; Wang M; Feng H; Geekiyanage S; Davidson AJ; Chen J Cell Physiol Biochem; 2019; 52(2):156-171. PubMed ID: 30816665 [TBL] [Abstract][Full Text] [Related]
12. Glucose and Blood Pressure-Dependent Pathways-The Progression of Diabetic Kidney Disease. Patel DM; Bose M; Cooper ME Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210089 [TBL] [Abstract][Full Text] [Related]
13. Might hyperbaric oxygen therapy (HBOT) reduce renal injury in diabetic people with diabetes mellitus? From preclinical models to human metabolomics. Harrison LE; Giardina C; Hightower LE; Anderson C; Perdrizet GA Cell Stress Chaperones; 2018 Nov; 23(6):1143-1152. PubMed ID: 30374882 [TBL] [Abstract][Full Text] [Related]
14. Oxidative stress as a culprit in diabetic kidney disease. Su S; Ma Z; Wu H; Xu Z; Yi H Life Sci; 2023 Jun; 322():121661. PubMed ID: 37028547 [TBL] [Abstract][Full Text] [Related]
15. The Warburg Effect in Diabetic Kidney Disease. Zhang G; Darshi M; Sharma K Semin Nephrol; 2018 Mar; 38(2):111-120. PubMed ID: 29602394 [TBL] [Abstract][Full Text] [Related]
16. Berberine protects against diabetic kidney disease via promoting PGC-1α-regulated mitochondrial energy homeostasis. Qin X; Jiang M; Zhao Y; Gong J; Su H; Yuan F; Fang K; Yuan X; Yu X; Dong H; Lu F Br J Pharmacol; 2020 Aug; 177(16):3646-3661. PubMed ID: 31734944 [TBL] [Abstract][Full Text] [Related]
17. Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease. Hasegawa S; Inagi R Curr Diab Rep; 2021 May; 21(7):21. PubMed ID: 33974145 [TBL] [Abstract][Full Text] [Related]
18. Mitochondrial dynamics and diabetic kidney disease: Missing pieces for the puzzle of therapeutic approaches. Narongkiatikhun P; Chattipakorn SC; Chattipakorn N J Cell Mol Med; 2022 Jan; 26(2):249-273. PubMed ID: 34889040 [TBL] [Abstract][Full Text] [Related]
19. AKAP1 contributes to impaired mtDNA replication and mitochondrial dysfunction in podocytes of diabetic kidney disease. Feng J; Chen Z; Ma Y; Yang X; Zhu Z; Zhang Z; Hu J; Liang W; Ding G Int J Biol Sci; 2022; 18(10):4026-4042. PubMed ID: 35844803 [TBL] [Abstract][Full Text] [Related]
20. Tumor Necrosis Factor Receptor-Associated Protein 1 Protects against Mitochondrial Injury by Preventing High Glucose-Induced mPTP Opening in Diabetes. Liu L; Zhang L; Zhao J; Guo X; Luo Y; Hu W; Zhao T Oxid Med Cell Longev; 2020; 2020():6431517. PubMed ID: 32215175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]